机译:利妥昔单抗会加重既往的低丙种球蛋白血症吗?
Department of Immunology, Directorate of Laboratory Medicine, Heartlands Hospital NHS Trust, Bordesley Green East, Birmingham B9 5SS, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
Department of Haematology, Coventry and Warwickshire University Hospital, Coventry, UK;
rnDepartment of Respiratory Medicine, Coventry and Warwickshire University Hospital, Coventry, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
rnDepartment of Immunology, Heartlands Hospital, Birmingham, UK;
机译:Rituximab相关的Hypogamaglobulina血症在自身免疫性疾病中:长期结果
机译:惰性非霍奇金淋巴瘤利妥昔单抗和氟达拉滨后继发性低丙种球蛋白血症的风险:一项回顾性队列研究
机译:Rituximab在Systemic Lupus红斑狼疮中的长期安全性:重复循环与低血管内血症的低速率相关
机译:具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
机译:增强利妥昔单抗治疗:分析利妥昔单抗与人类补体途径之间的相互作用。
机译:艾滋病患者的AZT治疗能否加重既往的CMV视网膜炎?
机译:Rituximab疗法后的低磷胶质血症